M- As you know also the review includes a continuous communication between the FDA and Amarin … and JT know 28th by 25 of June.
Yes, everything is possible ... maybe the FDA has to interview the 8,000+ patients in the R-IT tö avoid the possibility that the data was created by Amarin only …